Epoetin alfa Other names: Erythropoietin

PubChem compound: 92043599

Active ingredient description

Epoetin alfa is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of red blood cell (RBC) production. Epoetin alfa is involved in all phases of erythroid development, and has its principal effect at the level of erythroid precursors.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
B03XA01 Erythropoietin B Blood and blood forming organs → B03 Antianemic preparations → B03X Other antianemic preparations → B03XA Other antianemic preparations
Discover more medicines within B03XA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ABSEAMED Solution for injection in a pre-filled syringe European Medicines Agency (EU) MPI, EU: SmPC

External identifiers

CAS Substance: 113427-24-0
DrugBank Drug: DB00016
KEGG Drug: D03231
PubChem Compound: 92043599
RxNorm Ingredient: 2047589
SNOMED-CT Concept: 386947003
Epoetin alfa (substance)
SNOMED-CT Concept: 83042003
Erythropoietin (substance)
UNII Identifier: 64FS3BFH5W
EPOETIN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.